Research Article

A Redox-Sensitive Micelle-Like Nanoparticle Self-Assembled from Amphiphilic Adriamycin-Human Serum Albumin Conjugates for Tumor Targeted Therapy

Table 1

The effects of ADR, HSA/ADR, and HSA-ADR formulation composition on their in vitro/vivo performance.

Size/nmIC50/μM/mVTumor inhibition rate (%)

ADR0.5 ± 0.2 0.058
HSA/ADR>1000 ± 2500.165~5–1022.91
HSA-ADR100 ± 100.031~5–1069.98

The tumor inhibition rate = .